Q32 Bio, Inc. (QTTB)
16.36
+0.39
(+2.44%)
USD |
NASDAQ |
Aug 24, 16:00
16.34
-0.02
(-0.12%)
After-Hours: 20:00
Q32 Bio Total Liabilities (Quarterly) : 9.962M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.962M |
| March 31, 2026 | 17.36M |
| December 31, 2025 | 19.76M |
| September 30, 2025 | 76.23M |
| June 30, 2025 | 78.35M |
| March 31, 2025 | 83.08M |
| December 31, 2024 | 86.66M |
| September 30, 2024 | 86.25M |
| June 30, 2024 | 90.70M |
| March 31, 2024 | 103.56M |
| December 31, 2023 | 118.53M |
| September 30, 2023 | 51.85M |
| June 30, 2023 | 49.96M |
| March 31, 2023 | 45.98M |
| December 31, 2022 | 50.49M |
| September 30, 2022 | 53.59M |
| June 30, 2022 | 44.32M |
| March 31, 2022 | 44.70M |
| Date | Value |
|---|---|
| December 31, 2021 | 42.07M |
| September 30, 2021 | 32.24M |
| June 30, 2021 | 34.34M |
| March 31, 2021 | 33.87M |
| December 31, 2020 | 67.74M |
| September 30, 2020 | 58.14M |
| June 30, 2020 | 63.53M |
| March 31, 2020 | 62.25M |
| December 31, 2019 | 52.06M |
| September 30, 2019 | 58.94M |
| June 30, 2019 | 56.41M |
| March 31, 2019 | 58.76M |
| December 31, 2018 | 62.74M |
| September 30, 2018 | 55.64M |
| June 30, 2018 | 43.52M |
| March 31, 2018 | 40.84M |
| December 31, 2017 | 39.22M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Rallybio Corp. | 3.567M |
| Beam Therapeutics, Inc. | 318.91M |
| C4 Therapeutics, Inc. | 112.14M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.87M |
| Shareholders Equity (Quarterly) | 105.90M |
| Debt to Equity Ratio | 0.05 |
| Current Ratio | 20.28 |
| Net Debt Paydown Yield | 0.89% |